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Micro- and nanogels with labile crosslinks – from
synthesis to biomedical applications
Xuejiao Zhang, Shashwat Malhotra, Maria Molina and Rainer Haag*
Micro- or nanosized three-dimensional crosslinked polymeric networks have been designed and
described for various biomedical applications, including living cell encapsulation, tissue engineering, and
stimuli responsive controlled delivery of bioactive molecules. For most of these applications, it is
necessary to disintegrate the artificial scaﬀold into nontoxic residues with smaller dimensions to ensure
renal clearance for better biocompatibility of the functional materials. This can be achieved by
introducing stimuli-cleavable linkages into the scaﬀold structures. pH, enzyme, and redox potential are
the most frequently used biological stimuli. Moreover, some external stimuli, for example light and
additives, are also used to trigger the disintegration of the carriers or their assembly. In this review, we
highlight the recent progress in various chemical and physical methods for synthesizing and crosslinking
micro- and nanogels, as well as their development for incorporation of cleavable linkages into the
network of micro- and nanogels.
1. Introduction
Micro- and nanogels are crosslinked hydrogel particles with three-
dimensional networks composed of water soluble/swellable
polymers.1,2 This composition entails elastic moduli in the range
of 0.1–100 kPa, which makes them a primary soft matter.3
Like hydrogels, their features are: high water content, biocom-
patibility, and desirable chemical and mechanical properties.4
In addition, their tunable size from nanometers (nanogels) to
micrometers (microgels),3,5 large surface area for multivalent
bioconjugation, and interior network for the incorporation of
biomolecules make them more advantageous than micelles,
vesicles, liposomes, polymer prodrugs, etc. for biomedical appli-
cations.1 Apart from drug delivery applications, micro- and nano-
gels also have great potential in the areas of bioimaging,6–12
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sensing,10,13–20 antifouling,21,22 DNA or siRNA delivery,23–30 and
tissue engineering,31–33 etc.
A stable blood stream in the delivery system is highly desirable
for in vivo applications during systemic administration. Cross-
linked networks, especially covalently crosslinked micro- and
nanogels, can prevent leakage of the payload, which enhances
the therapeutic eﬃciency of the given drug. Upon reaching the
target sites, the drug payload should be eﬀectively released from
the cargo. Therefore, the carriers are required to be able to
respond to the relevant stimuli of the targeted disease, which is
especially important for the burst release systems. Moreover,
cytotoxicity is a crucial criterion in designing delivery vehicles.
The degradable carrier systems not only facilitate drug release
upon certain stimuli, but can also decrease the inherent toxicity
by avoiding accumulation of the carrier vehicle via clearance from
the body, after they complete their delivery tasks.
Cleavable linkages and degradable polymer backbones or
pendant groups are often used to form degradable gel networks.
Introducing reversible crosslinking groups onto precursor mole-
cules that form labile crosslinkages via gelation, however, is most
commonly applied to fabricate degradable micro- and nanogels.
Delivery of bioactive molecules is one of the most relevant
fields for the applications of micro- and nanogels. Various
environmental stimuli, including internal (pH, redox potential,
and enzyme) and external (light and additives), have been used
to trigger the dissociation of micro- and nanogels, facilitating the
drug release. Disulfide bonds are of great interest for making
micro- and nanogels, since they are prone to rapid cleavage
because of the high redox potential inside the cells.34–38 Another
important intracellular signal, acidic pH, can trigger the degrada-
tion of micro- and nanogels with acid-cleavable linkages into the
corresponding precursors or small molecules.29,39–41 In addition,
enzymes, existing with concentration specialty in different cells
and tissues, are also used as an intracellular signal to induce
site-specific drug release.42,43
With a focus on the cleavable linkages utilized in the cross-
linked network of micro- and nanogels, this review goes beyond
previous overviews. The first half section of this review spot-
lights the recent progress of synthetic strategies to produce
covalently and supramolecular crosslinked micro- and nanogels.
In the second half, cleavable linkages which are used in
designing degradable micro- and nanogels have been highlighted.
We emphasize the importance of degradable linkers which
are incorporated in the network of biodegradable micro- and
nanogels and subsequently aﬀect their biomedical eﬃcacies
as well as their fate.
2. Strategies to produce micro- and
nanogels
A wide variety of methodologies have been developed to prepare
micro- and nanogels. In the current review, we focus on inverse
miniemulsion, microfluidics, and inverse nanoprecipitation which
are important techniques used during the synthesis of micro-
and nanogels. In brief, inverse miniemulsion is a water-in-oil
(W/O) heterogeneous polymerization process, which contains
template nanodroplets formed by oil-soluble surfactants in a
continuous organic medium.44 In the microfluidic method, glass
capillary devices or devices made by soft lithography, normally
composed of polydimethylsiloxane (PDMS), can be used for
droplet fabrication.4 The nanoprecipitation technique is novel for
preparing hydrophilic nanogels.45 Size defined nanogel particles
are generated during in situ crosslinking of the precursors in
the surfactant free water droplet.
Currently, covalent crosslinking (including polymerization
of low molecular weight monomers as well as crosslinking of
macromolecular precursors) and supramolecular crosslinking
approaches can be used for the preparation ofmicro- and nanogels.
Covalently crosslinkedmicro- and nanogels are formed by coupling
reactive functional groups, which allow tuning of the structure
and properties of the gel particles. By introducing labile bonds
into the networks during covalent crosslinking, a variety of
degradable micro- and nanogels were synthesized for drug
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delivery applications. Supramolecular crosslinked micro- and
nanogels are based on the self-assembly of polymers through
noncovalent interactions. The details of these strategies are
discussed in the subsequent sections.
2.1. Covalent crosslinking
Covalent crosslinking methodologies are the basis for covalent
coupling of the reactive functional groups in the low molecular
weight monomers or macromolecular precursors to form the
gel networks. Micro- and nanogels formed by covalent bonds
via chemical crosslinking possess colloidal stability under
in vivo conditions, which is essential for leakage of drug release
induced by unwanted dissociation of the gel network. Covalent
crosslinking strategies mainly include radical polymerizations,
click chemistries, Schiﬀ-base reaction, thiol–disulfide exchange
reaction, and photoreactions (see Table 1).
2.1.1. Radical polymerization. Radical polymerization, espe-
cially living radical polymerization such as atom transfer radical
polymerization (ATRP), nitroxide-mediated polymerization (NMP),
and reversible addition–fragmentation transfer (RAFT), have been
used to synthesize micro- and nanogels.46,47 Free radicals, normally
generated from the initiator molecules, are used to initiate the
polymerization, and monovinylic monomers are crosslinked
with di- or multifunctional crosslinkers to form the micro- and
nanogel networks within preformed colloidally self-assembled
droplets.46 Some important examples in this category are listed
in the following.
Matyjaszewski et al. have synthesized stable biodegradable
nanogels by an ATRP of poly(oligo(ethylene oxide) monomethyl
ether methacrylate) (OEOMA) in inverse miniemulsion in the
presence of a disulfide-functionalized dimethacrylate (DMA)
crosslinker (Fig. 1).48 These nanogels are biodegradable in the
presence of the tripeptide, glutathione, which not only triggers
the release of the encapsulated payload, including rhodamine 6G
and doxorubicin (DOX), but also facilitates the clearance of blank
carriers. Furthermore, the OH-functionalized nanogels can be
easily decorated with biotin via an esterification reaction.
Matyjaszewski and coworkers have further synthesized bio-
compatible and uniformly crosslinked nanogels based on
poly(ethylene oxide) by inverse miniemulsion ATRP. This nano-
gel system was capable of encapsulating and delivering a variety
of payloads, including inorganic, organic, and biological mole-
cules. The endocytotic properties of these nanogels make them
good candidates for various drug delivery applications.49 They
also used a genetically engineered protein, which contained a
nonnatural amino acid with an ATRP initiator, to fabricate protein–
nanogel hybrids by electron transfer (AGET) ATRP in inverse
miniemulsion.50 The green fluorescent protein (GFP), which
was covalently conjugated into the nanogels, preserved its native
tertiary structure, thus demonstrating its potential use for
controlled release applications.
Compared to nanogels prepared by the conventional radical
polymerization, nanogels synthesized via ATRP have more
advantages, such as higher swelling ratios, better colloidal
stability, more homogenous and controlled structures, and
controlled degradation.44,50 However, remaining copper salts
can be problematic for in vivo applications.
In addition to ATRP, RAFT polymerization has also been used for
the fabrication of nanogels. Yan et al. have reported the synthesis
of cationic nanogels by a one-step surfactant-free RAFT process.
An amphiphilic PEGylatedmacroRAFT agent (mPEG550-TTC) was
used to form and stabilize the micelle, where the polymerization
and crosslinking of the N,N0-dimethylaminoethyl methacrylate
(DMAEMA) monomer were performed.51 Thermoresponsive, acid
Table 1 Covalent crosslinking reactions for micro- and nanogel formation
Reactions Reacting groups Reaction conditions Characterization Applications
Radical polymerization Free radical Heating, light, or
redox initiated




CuAAC Azide and alkyne Copper catalyzed Fast, versatile, regiospecific,
inert to biological molecules
Protein delivery,45 bone
targeting57
SPAAC Azide and cyclooctyne pH 7.4 Catalyst-free, tedious synthesis Cell encapsulation32
Copper free
click chemistry








Thiol and a, b-unsaturated
carbonyl group (acrylates
and maleimides)
pH 6–8, no catalyst Fast reaction kinetics Template for meso-
porous silica
synthesis64
Schiﬀ-base reaction Aldehyde and amine or
hydrazide
No catalyst Mild reaction conditions Protein delivery,65
functional surface66









Amide-based crosslinking Amine and carboxylic acids
or activated ester









Enzyme-catalyzed crosslinking Thiol HRP catalyzed No H2O2 needed Cell and protein
encapsulation96
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degradable core-crosslinked nanogels were synthesized by the
group of Narain via the RAFT polymerization technique. These
nanogels can be eﬃciently degraded and release the encapsulated
protein below pH 6.52
2.1.2. Click chemistry
2.1.2.1. Copper-catalyzed azide–alkyne Huisgen cycloaddition
(CuAAC). The CuAAC reaction is a modular approach to couple
two reactive components in a fast, versatile, regiospecific, and
highly efficient reaction.53 Normally, click reactions are performed
under mild conditions without the formation of byproducts
(atom conversation). Furthermore, both azides and alkynes are
inert towards biological molecules,54 which is propitious for the
synthesis of biomaterials. Our group recently reported the
synthesis of hydrophilic polyglycerol based nanogels crosslinked
through a facile click reaction by miniemulsion.55,56 Dendritic
polyglycerol (dPG) was modified with alkynes or azides to
form the complementary reactants, that were miniemulsified
in equimolar amounts, which, after catalysis of copper salts,
resulted in crosslinked particles. Later on, a mild, surfactant
free inverse nanoprecipitation method was developed in our
group, through which polyglycerol nanogels were obtained with
a defined size from 100 nm to 1000 nm by bioorthogonal copper
catalyzed click chemistry (Fig. 2a). Biodegradability was achieved
by the introduction of benzacetal bonds into the nanogel network.
Labile enzymes were well-protected by these nanogels in the
process of encapsulation and retained their activity and structural
integrity after being released.45
Similarly, Anderson et al. have generated dextran based
nanogels with controllable surface functionalities and targeting
properties by a facile approach via click chemistry in an inverse
emulsion.57 Cu+2 and sodium ascorbate were used to initiate the
click reaction between alkyne- and azide–dextran in the aqueous
phase before emulsification. The free alkyne/azide groups after click
chemistry allowed surface modification of nanogels, for example,
by azido-containing bisphosphonate and alkyne-containing
Alexa Fluor 647. The nanogels were degradable in the presence
of enzyme dextranase and showed modular distribution and
targeting properties for bone disease. However, the incomplete
removal of copper catalysts is problematic for in vivo applications.
Therefore, copper-free click methods can be advantageous.
2.1.2.2. Copper-free click chemistry.Most recently, copper-free click
reactions, including strain-promoted azide–alkyne cycloaddition
(SPAAC), thiol–ene click reaction, and Michael addition reaction,
make it possible to synthesize micro- and nanogels without any
potentially toxic catalysts that are commonly required,58 thus
beneficial for biomedical applications.
2.1.2.2.1. Strain-promoted azide–alkyne cycloaddition (SPAAC).
CuAAC is not suitable for encapsulating labile biomolecules since
copper can be cytotoxic for living cells.59 The noncytotoxic and
efficient SPAAC have been developed as an alternative to CuAAC
for synthesizing hydrogels for biomedical applications, especially
in the field of tissue engineering.41,60 Recently, our group has
developed pH-cleavable cell-laden microgel systems by combining
bioorthogonal SPAAC and droplet-based microfluidics for the
encapsulation and programmed release of cells (Fig. 3a–c).32
Homo-bifunctional poly(ethylene glycol)-dicyclooctyne (PEG-DIC)
and dPG-polyazide were prepared and used as macromonomers
for in situ crosslinking to obtain microgels by SPAAC. The viability
of the encapsulated cells can be retained for a long time when
cultured inside the microgels.
2.1.2.2.2. Thiol–ene click reaction. In addition to SPAAC, the
thiol–ene reaction is another click reaction that does not need a
metal catalyst. Typically, thiols are reacted with unsaturated groups,
e.g. alkenes, in a thiol–ene reaction. The research group of Jiang has
fabricated a multi-responsive microgel based on thiol–ene photo-
click crosslinking after the co-assembly of the amphiphilic allyl
glycidyl ether ended hyperbranched poly(ether amine) (hPEA-
AGE) and pentaerythritol tetra(3-mercaptopropionate) (PTMP).61
Fig. 1 (a) Chemical structures of the crosslinker DMA and glutathione ethyl ester. (b) Synthesis of biodegradable nanogels by ATRP and functionalization
of nanogels with biotin. Reprinted with permission from ref. 48. Copyright 2007 American Chemical Society.
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Fig. 2 (a) Reverse nanoprecipitation process for nanogel formation. Injection of an aqueous solution of azide functionalized polyglycerol (red spheres), alkyne
functionalized polyglycerol (blue spheres), and a 3D protein structure. Formation of a particle template after the aqueous phase diﬀused into the acetone phase.
Crosslinking by CuAAC is achieved by upconcentration. (b) Degradation of polyglycerol nanogels at diﬀerent pH determined by UV/vis absorption. (c) Release
kinetics of protein from the nanogel network at diﬀerent pH determined by HPLC. Reproduced from ref. 45. Copyright 2013 Elsevier Ltd.
Fig. 3 Cell encapsulation and release: (a) Preparation of dPG-azide precursors and injection of precursors and cells into a microfluidic device.
(b) Formation of cell-laden microgels with high viability determined by fluorescent live-dead assays. (c) Degradation of microgels. (d) Degradation of
microgel particles at diﬀerent pH values and fluorescence images of one microgel particle incubated at pH 4.5 (e) at the beginning, (f) half-completed
degradation, and (g) fully-completed degradation. Reprinted with permission from ref. 32. Copyright 2013 Wiley-VCH.
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After self-assembly, the inner core which is composed of
hydrophobic PPO chains and PTMP was crosslinked upon
irradiation by UV light.
2.1.2.2.3. Michael addition. Typically, the Michael addition
reaction is the base-catalyzed nucleophilic addition of a Michael
donor (i.e. enolate anion) to an activated a,b-unsaturated carbonyl-
containing compound, a so-called Michael acceptor.62 Michael
addition has also been used to make micro- and nanogels without
any metal additive.
Seiﬀert et al. developed monodispersed cell-laden microgels
via the nucleophilic Michael addition of dithiolated PEG with
acrylated hyperbranched polyglycerol (hPG) through droplet
microfluidic templating (Fig. 4).63 After the formation of the
premicrogel upon injecting both precursor solutions together
with a cell-containing solution into a microfluidic device, the
gelation proceeds to produce cell-laden microgels.
The research group of Zhang has developed degradable
nanogels with cleavable disulfide bonds and amine groups in
a network that has been crosslinked by the Michael addition of
triethylenetetramine (TETA) or tetraethylenepentamine (TEPA)
with N,N0-bis(acryloyl)cystamine (BAC).64 As shown in Fig. 5,
mesoporous silica spheres were obtained after hydrolyzing tetra-
ethyl orthosilicate (TEOS) that had been catalyzed by the amine
groups inside the nanogel network and after removing the
nanogel scaﬀold by cleaving the disulfide bonds.
2.1.3. Schiﬀ-base reaction. The Schiﬀ-base reaction occurs
between aldehydes and amines or hydrazide containing com-
pounds. It has been used to generate biocompatible gels due to
its mild reaction conditions.
Qu and Yang et al. have generated protein nanogels crosslinked
by a one-step Schiﬀ-base reaction between the amino groups of
urokinase and benzaldehyde bifunctionalized PEG.65 The for-
mation of imine bonds, which are stable under physiological
conditions and labile at acidic pH, makes these nanogels
promising candidates for the intracellular delivery of proteins.
Detrembleur et al. have described a novel approach to
fabricate antibacterial, antibiofilm, and antiadhesion platforms
based on functional nanogels, which were crosslinked through the
Schiﬀ-based reaction and/or Michael addition reaction between
poly(methacrylamide)-bearing quinone (Pox(mDOPA)) and poly(allyl-
amine) (PAH).66 In order to introduce the antibacterial properties,
silver was loaded into the nanogels, which was beneficial for
the Michael addition but prevented the Schiﬀ-base formation
due to the complexation of quinone groups with silver.
2.1.4. Thiol–disulfide exchange reaction. In the thiol–disulfide
exchange reaction, the deprotonated free thiol displaces one
sulfur of the disulfide bond in the oxidized species.67 This is
essential for cellular disulfide bond formation and is now
commonly used in the formation of nanogels. Zhong et al.
prepared reversibly crosslinked dextran nanoparticles from
dextran–thioctic acid derivatives based on a thiol–disulfide
exchange reaction using a catalytic amount of dithiothreitol
(DTT).68 Thioctic acid is naturally produced in the human
body69 and shows no cytotoxicity even at high concentration.70
Recently, our group reported the preparation of a dual-responsive
prodrug nanogel for the covalent conjugation and intracellular
delivery of doxorubicin (DOX) through a thiol–disulfide exchange
reaction by an inverse nanoprecipitation method.38 As shown in
Fig. 6, the macromolecular precursor was synthesized by the
conjugation of thioctic acid with hPG. A predetermined amount
of DTT was used to initiate the thiol–disulfide exchange reaction by
cleaving the lipoyl ring in thioctic acid to the corresponding
dihydrolipoyl groups. The nanogel with a disulfide crosslinked
network can be degraded under intracellular reductive conditions
into small fragments, which are below the clearance limitation
of the kidneys (B50 kDa). DOX was conjugated with an acidic
Fig. 4 Formation of microgels by crosslinking hPG and PEG via Michael
addition. Reprinted with permission from ref. 63. Copyright 2012 American
Chemical Society.
Fig. 5 The formation of mesoporous silica spheres from hybrid silica
colloids by removal of the nanogels by DTT. Reprinted with permission
from ref. 64. Copyright 2009 American Chemical Society.
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labile hydrazone linker to form the prodrug nanogel, which can
efficiently deliver and release the drug payload into the nucleus.
Xu et al. have designed a nano cocktail of a nanogel system
by a thiol–disulfide exchange reaction that was initiated by
adding a deficient amount of tris(2-carboxyethyl)phosphine
(TCEP).37 This nanogel is sensitive to both acidic pH and redox
potential. Drug loaded nanogels, ND (nano DOX) and NCPD (a nano
cocktail of paclitaxel and DOX), are stable under physiological
conditions and yet spontaneously swell and quickly release their
payload after entering the cancer cells with the help of a targeting
peptide, cRGD. A synergistic anticancer effect is accomplished in
the case of NCPD owing to its elevated internalization and dual
responsiveness property.
The research group of Thayumanava has fabricated a series
of nanogel systems based on the thiol–disulfide exchange
reaction, which causes a self-crosslinking of pyridyl disulfide
(PDS) containing amphiphilic polymers.35,36,71–73 The addition
of deficient amounts of DTT reduces the controlled amount of PDS
groups to thiols, which further exchange with the remaining PDS
groups affording a crosslinked nanogel. In the process of thiol–
disulfide exchange, the byproduct pyridothione was formed. The
crosslinking density can be calculated by detecting the concen-
tration of pyridothione through UV-vis. By introducing tri-arginine,
which provides both the positive charge and cell-penetrating prop-
erty, to the surface of the charge-neutral nanogel, they successfully
combined the encapsulation of lipophilic small molecules and
binding proteins in one single nanogel system.73
Wu et al. have described an approach to fabricate controllable
micro- and nanogels via a pH-responsive thiol–disulfide exchange
reaction of the disulfide-linked core–shell hyperbranched polymer
through an inverse emulsion technique.43 In the process of
basification-triggered disulfide reshuffling, the shells dissociated
and the cores were crosslinked. By varying the gelation time, loose
and compact micro- and nanogels with distinct particle sizes and
swelling capacities were obtained.
2.1.5. Photo-induced crosslinking. Reactants containing a
photo-activatable group can be crosslinked by photo irradiation.
Zhao and coworkers have prepared photoresponsive nanogels via
photo-crosslinking based on the reversible photodimerization and
photocleavage of coumarin.74,75 A block of poly(ethylene oxide)
and a block of poly[2-(2-methoxyethoxy)ethylmethacrylate-co-4-
methyl-[7-(methacryloyl)oxyethyloxy]coumarin] (PEO-b-P(MEOMA-
co-CMA)) formed micellar aggregates when the temperature was
above its lower critical solution temperature (LCST), and the
dimerization of coumarin side groups was initiated upon UV
irradiation at l 4 310 nm via photo-crosslinking, generating
the water-soluble nanogels upon cooling to T o LCST.
Wang et al. have synthesized biodegradable nanogels by the
photo-crosslinking of salt-induced poly(ethyl ethylene phosphate)
(PEEP) assemblies by a template-free method.76 Upon addition of
salt, PEEP self-assembled into core–shell nanoparticles due to its
hydrophobic-to-hydrophilic transition property induced by salt. The
crosslinked hydrophilic nanogels were obtained after UV-irradiation
and removal of the salt by dialysis. Although photo-induced
crosslinking is highly efficient, the initiator may induce cytotoxi-
city in the produced gels.77 Therefore, it is important to choose
the photoinitiator to make biocompatible gel networks.
2.1.6. Amide-based crosslinking. Due to the high reactivity
with carboxylic acids, activated esters, isocyanates, etc., amine
groups can be used for synthesizing micro- and nanogels.78 This
facile methodology provides an opportunity to introduce various
stimuli-response properties into the nanogels by modulating the
structure of the diamine crosslinker.
Thayumanavan et al. have developed a facile approach to
synthesize hydrophilic nanogels based on a simple reaction between
pentafluorophenyl (PFP)-activated hydrophobic esters and diamine
crosslinkers.79 As shown in Fig. 7, PFPmoieties not only serve as the
crosslinking reagents, but are also used for further functionalizing
the nanogels and providing lipophilic domains inside the nanogel
for encapsulation of the hydrophobic drugs.
Kim et al. fabricated pH-responsive PEG-poly(aspartic acid)
(PEG-PAsp) nanogels by crosslinking the amine-reactive hydrophobic
poly(succinimide) (PSI) with the crosslinker hexamethylenediamine
(HMD) through a nucleophilic ring-opening reaction, followed
by hydrolysis of the hydrophobic core (Fig. 8).80 The crosslinking
degree was adjusted by varying the crosslinker feed ratio, and the
nanogel swelled in water up to 30 times its original volume.
Under acidic conditions, the deswelling of the nanogels retarded
the release of the protein payload.
Iturbe et al. have generated chitosan based nanogels by
reacting the amine of chitosan with dicarboxylic acid-decorated
chitosan in a water-in-oil (W/O) microemulsion.81 Two bio-
compatible dicarboxylic acids, polyethylene glycol dicarboxylic
acid (PEGdiacid) and tartaric acid, were used, whereby the PEG-
diacid was more eﬃcient than the tartaric acid upon crosslinking
with chitosan.
2.1.7. Boronic acid–diol complexation. The complexation
between boronic acid and 1,2- or 1,3-diols has been applied to
fabricate hydrogels34,82–87 and core-crosslinked micelles.88,89
Recently, boronate esters have also been utilized to prepare
nanogels. Ishihara et al. have prepared spherical polymeric
hydrogels via specific esterification between phenyl boronic
acid groups in poly(2-methacryloyloxyethyl phosphorylcholine-
co-n-butyl methacrylate-co-4-vinylphenyl boronic acid) (PMBV)
and hydroxyl groups in poly(vinyl alcohol) (PVA) using a flow-
focusing microfluidic channel device.90 The polymer distribution
Fig. 6 Synthetic approaches of nanogel and prodrug nanogel. Reprinted
with permission from ref. 38. Copyright 2014 Elsevier Ltd.
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in the gel was influenced by the PVA concentration, which was
expected to facilitate fine-tuning of the mechanical and permeation
properties of the hydrogel particles. Individual cells could be
encapsulated and remained viable in the hydrogel particles.
Narain et al. have made use of the boronic–diol complexation
to synthesize responsive hydrogels and nanogels by simply mixing
the well-defined glycopolymer and P(NIPAAm-st-MAAmBO)s
copolymers, which were statistically copolymerized from
N-isopropylacrylamide (NIPAAm) and 5-methacrylamido-1,2-
benzoxaborole (MAAm-BO) (Fig. 9a).91 As shown in Fig. 9b, upon
addition of a superfluous glucose, the glycopolymer dissociated
from the P(NIPAA90-st-MAAmBO12), which instantly associated
with the added free glucose molecules. When the clear solution
was dialyzed against an alkaline solution, spherical nanogels
could be obtained. As the small glucosemolecules passed through
the dialysis membrane, the P(NIPAA90-st-MAAmBO12) chain could
again gradually interact with glycopolymer chains.
Our group has recently developed a novel ATP- and
pH-responsive degradable nanogel system based on the complexa-
tion of 1,2-diols in dPG, and boronic acids, which are conjugated
with dPG as the macromolecular crosslinker (Fig. 10). dPG was
converted into 100% functionalized dPG-amine (dPGA), and then
2-[2-(2-methoxyethoxy) ethoxy] acetic acid was conjugated with
amine groups by amide coupling with the purpose of eliminating
the cytotoxic eﬀect induced by amines. The macromolecular
crosslinker, dPG-Am-PEG-FPBA, was synthesized via a Schiﬀ-base
reaction between the amino groups in dPGA and formyl groups in
2-formylphenylboronic acid (FPBA), followed by the reduction
with NaBH4. The dual-responsive nanogel, composed of dPG
as the scaﬀold and dPG-Am-PEG-FPBA as the macromolecular
Fig. 7 Schematic illustration of synthesis and surface modifications of the crosslinked nanogels. Reprinted with permission from ref. 79. Copyright 2012
American Chemical Society.
Fig. 8 Synthesis of the PEG–PAsp nanogel. Adapted from ref. 80. Copy-
right 2013 Royal Society of Chemistry.
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crosslinker, was fabricated via the surfactant-free inverse nano-
precipitation method.45,92
2.1.8. Enzyme-catalyzed crosslinking. Enzyme-catalyzed
crosslinking has been used for the preparation of hydrogels as
an innovative technology with greater eﬃciency than other cross-
linking methods due to its short reaction time, mild reaction
conditions, and high biocompatibility.93–95 The gelation kinetics,
depending on the structure and composition of the macromer,
the ratio of the reactants, and the enzyme concentration, are well-
controllable. Therefore, the enzyme-catalyzed reaction is suitable
for in situ gelation systems. So far, however, the enzyme-catalyzed
nanogels have not been widely investigated.
Fig. 9 (a) Formation of gels by boronic–diol interaction between P(NIPAAm-st-MAAmBO) and glycopolymers. (b) Formation of nanogels upon addition
of excess free glucose solution into the gel sample and extensive dialysis in pH 12 solution at 4 1C, and a TEM image of the nanogels. Reprinted with
permission from ref. 91. Copyright 2013 American Chemical Society.
Fig. 10 Synthetic approaches of boronic ester nanogels and Methotrexate (MTX)-loaded nanogels. Reprinted with permission from ref. 92. Copyright
2014 Wiley-VCH.
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Groll and coworkers have reported redox-sensitive disulfide-
crosslinked hydrogels and nanogels by horseradish peroxidase
(HRP)-mediated crosslinking without using hydrogen peroxide
(H2O2).
96 The cytocompatible hydrogels served as cell-laden
systems without destroying their vitality. By adding thiol-
decorated peptides during the formation of nanogels, peptide-
functionalized nanogels can be obtained. b-Galactosidase was
loaded as a model protein into the HRP crosslinked nanogel
and could be released after degrading the nanogels under the
cytosol’s reductive conditions.
Recently, our group developed biocompatible hydrogels based
on HRP catalyzed crosslinking of 3-(4-hydroxyphenyl) propionic
acid functionalized hyperbranched polyglycerol (hPG-HPA) in
the presence of H2O2 for living cells encapsulation (Fig. 11).
97
The formation of hydrogels can be triggered by glucose in the
presence of GOD and HRP since the oxidation of glucose by
glucose oxidase (GOD) can produce H2O2.
2.1.9. Siloxane crosslinking. Jandt et al. have fabricated
temperature-sensitive poly(N-isopropylacrylamide) microgels based
on the hydrolysis/condensation of siloxane groups by free radical
precipitation.98,99 The thermal initiator, ammonium persulfate
(APS), was used to initiate the radical copolymerization of NIPAAm,
as well as to catalyze the hydrolysis/condensation of siloxane
groups due to the acidic environment caused by APS. This method
has not yet been used for biomedical gel synthesis.
In summary, the formation of micro- and nanogels by covalent
crosslinking approaches can maintain their stability in a complex
and harsh environment (e.g. in vivo conditions), prevent the
leakage of the encapsulated drug payload, and enhance their
therapeutic eﬃcacy. However, traditional covalent crosslinking
normally involves crosslinking agents, which sometimes cause
unwanted toxic eﬀects and damage the entrapped fragile sub-
stances, including proteins or cells. Therefore, more and more
biocompatible and bioorthogonal reactions are continuously
emerging in the field of biomedical gelation which also needs
further exploration.
2.2. Supramolecular crosslinking
Micro- and nanogels formed by supramolecular crosslinking
involve self-assembled aggregations based on various physical
interactions including ionic, hydrophobic, and hydrogen bonding.
Unlike the covalent crosslinking method, supramolecular
crosslinking does not need any crosslinking agent that might
cause unwanted interaction with the bioactive substances
during the encapsulation of biomacromolecules. Moreover,
the preparative conditions of supramolecularly crosslinked gels
are normally mild, mostly in water, which avoids the adverse
toxic eﬀects. However, gels formed by the supramolecular
crosslinking may possess less mechanical strength and stability
to face the harsh in vivo conditions present in blood circula-
tion which makes them less applicable than covalently cross-
linked gels.100
2.2.1. Ionic interaction. The research group of Ryu developed
a versatile method for synthesizing self-assembled supramolecular
nanogels by electrostatic interaction between positively charged
surfactant micelles and negative polypeptides.101 Below the critical
micelle concentration (CMC) of the small positive surfactants,
supramolecular ionic amphiphilies were formed due to the inter-
action between individual positive surfactants and negatively
charged gelatin B. Further self-assembly of the supramolecular
amphiphiles induced larger nanoaggregates that were driven by
the hydrophilic–hydrophobic balance. Above the CMC, the small
positive surfactants first self-assembled into positively charged
micelles and then interacted with gelatin B with negative charge
which resulted in core–shell-like aggregates. These core–shell-
like nanogel aggregates contained stable hydrophobic pockets
that prevented the hydrophobic guests from diffusing, thereby
increasing the encapsulation stability.
Fig. 11 Illustration of hPG-HPA hydrogel formation by HRP crosslinking. Reprinted with permission from ref. 97. Copyright 2014 American Chemical Society.
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Nakai and Akiyoshi et al. have developed anionic nanogels
based on the self-assembly of cholesteryl-group-bearing hyaluronic
acid (HA) for protein delivery.102 Compared to the conventional
non-ionic nanogels, the anionic HA nanogels can eﬃciently bind a
variety of proteins without denaturation. An injectable hydrogel was
formed by the association of HA nanogels induced by salt, resulting
in a sustainable release of recombinant human growth hormone
(rhGH) in rats for one week.
Lim et al. fabricated nanogels with pH-sensitivity and targeting
ability that were composed of CD44-receptor-targeting hyaluronic
acid (HA), pH-sensitive poly(b-amino ester) (PBAE), and near-
infrared (NIR) fluorescent indocyanine green (ICG) that can be
incorporated into the assembled structure of HA and PBAE poly-
mers based on the electrostatic and hydrophobic interactions.9
Upon decreasing the pH from 7.4 to 5.5, the nanogel disassembled
due to the protonated PBAE so that the fluorescence intensity
increased, which resulted in the liberation of the probes from
the nanogels.
2.2.2. Hydrophobic interaction. Cholesterol is frequently
used as a hydrophobic moiety to induce the self-assembly of
amphiphilic copolymers to form a nanogel structure based on
the hydrophilic/hydrophobic balance.7,8,31,103–107 Akiyoshi et al.
fabricated hydrogel nanoparticles (nanogels) by the self-assembly
of cholesterol-bearing pullulan (CHP).108,109 CHP nanogels were
physically entrapped into a three-dimensional hydrogel network,
which was covalently crosslinked by HA modified 2-aminoethyl
methacrylate via Michael addition. The embedded nanogel and
hydrogel matrix synergetically achieved both loading and con-
trolled release of protein without denaturation.104 Akiyoshi et al.
then made hybrid PEG hydrogels based on the crosslinking of
CHP nanogels and nanogel-coated liposome complexes with
pentaerythritol tetra(mercaptoethyl) polyoxyethylene by Michael
addition. During the hydrolysis of the hydrogel under physio-
logical conditions, the nanogel is released first and then the
nanogel-coated liposomes. A variety of guest molecules can be
loaded inside the nanogel/liposomes and also released in a
controllable two-step profile in the hybrid hydrogels, which
exhibit their capability for multiple delivery of drugs, proteins,
or DNA.107 Moreover, they generated a raspberry-like assembly
of nanogels based on the Michael addition by crosslinking an
acrylate-modified cholesterol-bearing pullulan nanogel (CHPANG)
with thiol-modified poly(ethylene glycol) (PEGSH) (Fig. 12).103
Interleukin-12 (IL-12) encapsulated with high efficiency (96%) in
these nanogels can maintain a high level in mice plasma after
subcutaneous injection.
Later on, the same research group created fast-degradable
hydrogels by crosslinking the aggregation of cholesteryl- and
acryloyl-bearing pullulan (CHPOA) nanogels with PEGSH
(Fig. 12). Two distinct growth factors, recombinant human
bone morphogenetic protein 2 (BMP2) and recombinant
human fibroblast growth factor 18 (FGF18), were encapsulated
in the nanogels, and CHPOA–FGF18 + BMP2/hydrogel could more
strongly enhance bone repair than the single protein-loaded
hydrogel system.31
Lim et al. have reported the synthesis of a new near-infrared
(NIR)-emitting polymer nanogel (NIR-PNG) using self-assembled
pullulan–cholesterol nanogels conjugated with IRDye800.7 The
resultant systems could be used for sentinel lymph node (SLN)
mapping in both small and large animal models by optimizing
the size for lymph node uptake.
Gref and coworkers presented a spontaneous formation of
supramolecular nanoassemblies (nanogels) based on inclusion com-
plexes between alkyl chain containing dextran and the molecular
cavities containing b-cyclodextrin polymer.110 The uncomplexed
cyclodextrin units were accessible for guest molecules, such as
benzophenone or tamoxifen, representing the carrier potential
of nanogels. They have further studied the stability of these
supramolecular nanoassemblies (nanogels).111 At low concen-
trations, the mean diameter of the nanogel suspensions did
not vary much during storage. However, the concentrated ones
Fig. 12 Structures of CHPOA, CHPANG, and PEGSH. Adapted from ref. 31 and 103. Copyright 2012 and 2009 Elsevier.
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tended to destabilize over time with increased mean diameter
due to particle aggregation and/or fusion.
Youn et al. prepared inhalable nanogels by the self-assembly
of deoxycholic acid-modified glycol chitosan (DOCA-GC) with
palmityl acylated exendin-4 (Ex4-C16) based on hydrophobic
and ionic interactions.112 DOCA-GC nanogels showed tolerable
cytotoxicity and did not induce any significant diﬀerence in the
tissue histology of mouse lungs after pulmonary administration.
The Ex4-C16-loaded DOCA-GC nanogels represented a sustained
inhalation delivery system for treating type 2 diabetes. Normally,
multiblock copolymers or graft copolymers, composed of a water-
soluble polymer backbone, are capable of forming self-assembled
aggregated gel particles.
Davis and coworkers presented the first in-human phase I
clinical trial of the targeted siRNA delivery system based on the
inclusion complexes of cyclodextrin-decorated polymer (CDP)
and adamantine terminated PEG (AD-PEG) (Fig. 13).113 A human
transferrin protein (TF) targeting ligand was introduced on the
exterior of the nanoparticles to attach TF receptors on the surface
of the cancer cells. The targeted nanoparticles exhibited dose-
dependent accumulation in human tumors, which induced
specific gene inhibition.
2.2.3. Hydrogen bonding. The supramolecular hydrogen
bonding between the functional groups in the polymers, including
–OH, –NH2 etc., is an option for fabricating supramolecularly
crosslinked gel networks. However, the network formed via hydro-
gen bonding lacks stability, since hydrogen bonding depends on
the type of solvents and pH of the solution. The group of Park
developed heparin nanogels based on nanocomplexes between
thiolated heparin and PEG via hydrogen bonding, followed by
the intermolecular crosslinking of disulfide bonds between
thiolated heparin molecules by ultrasonication.114 These nano-
gels not only enhanced the internalization of heparin but also
released them in the reductive cytosol environment, which
resulted in the inhibition of cell proliferation and caspase-
mediated apoptotic cell death.
Zhou et al. reported in situ immobilization of CdSe quantum
dots (QDs) into the chitosan-based hybrid nanogels formed either
by noncovalent physical associations, such as secondary forces
(hydrogen bonding or hydrophobic association) and physical
entanglements, or by covalent crosslinkages.19 Unfortunately,
these physically associated hybrid nanogels were unstable even
at physiological pH, inducing significant cytotoxicity.
Feng et al. have constructed pH-sensitive nanohydrogels
that were based on the supramolecular hydrogen-bonding of
a cationic hyperbranched polycarbonate.115 The nanohydrogels
expanded to a high degree in response to slightly decreased pH
values from 7.4 to 6.6 due to the charge repulsion, which resulted
in local release of the drug in the acidic microenvironment.
Seiﬀert and coworkers prepared a series of poly(N-isopropyl-
acrylamide) (pNIPAAm) with diﬀerent types of crosslinkable
side groups. By adding low molecular weight linkers that are
complementary to the motifs on the polymer, diﬀerent supra-
molecular polymer networks with greatly varying rheological
properties were formed due to multiple hydrogen bonding.116
Then they fabricated linear polyglycerol-based multiresponsive
supramolecular hydrogels crosslinked by hydrogen bonding, metal
complexation, or both (Fig. 14).117 Linear azide-functionalized
polyglycerol is modified either with diaminotriazine and terpyridine
or with cyanurate and terpyridine. Gelation occurs after mixing
the aqueous solution of both compounds because of the multiple
hydrogen bonding or the metal complexation in the presence of
an iron(II) salt. Metal complexation-based crosslinking is used to
develop hydrogels,118–122 but has not been applied for the fabrica-
tion of micro- and nanogels till now.
It is not easy to prepare supramolecularly crosslinked micro-
and nanogels with high stability and controlled size because
the noncovalent bonds, including ionic interaction, hydrophobic
interaction, and hydrogen bonding, are not strong enough.
Nevertheless, their preparation process is relatively easy because
Fig. 13 Formation of targeted nanoparticles. Reprinted with permission
from ref. 113. Copyright 2010 Nature Publishing Group.
Fig. 14 Supramolecular hydrogel formation crosslinked by multiple
hydrogen bonding and metal complexation. Reprinted with permission
from ref. 117. Copyright 2014 American Chemical Society.
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it does not require toxic reagents or catalysts and does not
produce byproducts, which makes it favorable for biomedical
applications. Furthermore, multivalent systems, containing multiple
interactions, can further enhance their stability.123
3. Cleavable covalent crosslinks
The stability of crosslinked micro- and nanogels is essential
under certain circumstances, i.e. during blood circulation for
drug delivery. However, permanent stability is not an option in
some applications as the entrapped payload needs to be released
at the target site for its biological functions. By introducing labile
linkers into the scaﬀolds of the micro- and nanogels, reversible
crosslinking can be realized at the target site. In this case, the
stable structure of covalently crosslinked micro- and nanogels is
broken down in response to certain stimuli. In the subsequent
sections, we will focus on the cleavable crosslinks, including
pH-cleavable, photo-cleavable, redox-cleavable, enzyme-cleavable,
additive-cleavable crosslinks, etc. (see Table 2), which help to
release the payload at the diseased site in a more eﬃcient
manner.
3.1. Acid-cleavable
The introduction of acid-cleavable crosslinks into the gel net-
works should favor the dissociation of gels, since the acidic
conditions present in tumor tissues, endosomes (5.5–6.5),
or lysosomes (4.5–5.5) can be responsible for the cleavage of
acid-sensitive crosslinks. The pH value in normal tissues and
blood is around 7.4, while in tumor or inflammatory tissues,
the environment is 0.5–1.0 pH units lower. During cellular uptake,
the vehicles first reach early endosome with a pH about 6, followed
by late endosome, where the pH drops to 5–6. Subsequently, the
vehicles can reach a more acidic compartment, the lysosome
(pH B 4.5).124–126 These pH gradients existing in biological
systems can be used as a trigger to fabricate acid sensitive gel
systems for biomedical applications. Various acid-cleavable
linkers have been applied into micro- and nanogel networks
such as acetals or ketals, esters, imine, hydrazone, and vinyl
ether. The incorporation of such linkers inside the micro- and
nanogels will be examined in detail in the upcoming sections.
3.1.1. Acetal and ketal linker
3.1.1.1. Acetal linker. Bulmus and coworkers have prepared acid-
labile microgel particles with divinyl-functionalized acetal-based
crosslinkers via an inverse emulsion polymerization technique.127
They have synthesized a number of di(acrylate)-functionalized,
acetal-based crosslinkers, and found that the para-substituent
group on the benzene ring of the benzaldehyde acetal and the
microenvironment polarity of the crosslinker structure can aﬀect
the hydrolysis rate. Crosslinkers, which were stable at neutral pH
for a long time and underwent complete hydrolysis at slightly
acidic pH in less than 1 h, were obtained. Rhodamine B-labeled
dextran and BSA, as the model biomacromolecules, could be
eﬃciently loaded into the microgels. The drug release could be
controlled by adjusting the pH of the environment, which is in
accordance with particle degradation.
Our group has recently generated biodegradable nanogels
based on dendritic polyglycerol via a mild and surfactant free
inverse nanoprecipitation approach by CuAAC.45 Benzacetal
bonds, as the cleavable linkers, retain stability at physiological
pH and enable the nanogels to eﬃciently degrade into small
fragments under acidic conditions with a half-life of 11 h at pH
5.0 (Fig. 2b). Asparaginase, which was used as a biomacro-
molecular protein model, was encapsulated into the protein
resistant polyglycerol network with 100% eﬃcacy and released
with full enzyme activity by acid-triggered degradation of the
nanogels (Fig. 2c). To further understand the degradation
process on the molecular scale, atomic force microscopy (AFM)
was used for the real time visualization of pH-responsive nano-
gels based on linear- and dendritic polyglycerol with acid labile
acetal bonds. As shown in Fig. 15, at pH 9, the nanogels retain
their size and shape due to the stable conditions of acetal bonds,
whereas, decreasing the pH to 4 induces the acetal cleavage,
resulting in particle erosion.128
Furthermore, our group also reported the fabrication of
acid-labile cell-laden microgels by combining SPAAC and
droplet-basedmicrofluidics with diﬀerent substituted benzacetal
linkers, which makes the degradation kinetics of microgels
controllable in the pH range from 4.5 to 7.4 (Fig. 3d–g).32 The
encapsulated cells retained their viability while being cultured
inside the microgels and could be released without detrimental
effect triggered by lower pH (e.g. pH = 6.0).
The acid cleavability of benzacetals can be tuned by intro-
ducing substituents in the para position so that the hydrolysis
kinetics can be manipulated. Fre´chet et al. have developed
protein-loaded hydrogels and microgels crosslinked with an
acid-sensitive benzaldehyde acetal linker.40 In their research,
bisacrylamide acetal with a p-methoxy substituent was chosen
as the crosslinker and showed a rapid hydrolysis of microgels at
pH 5.0 with a half-life of 5.5 min, which is much faster than
that of other acetals.
3.1.1.2. Ketal linker. Berkland et al. have synthesized acid-
labile poly(N-vinylformamide) (PNVF) nanogels through a ketal-
containing crosslinker via inverse emulsion polymerization
(Fig. 16).129 The encapsulation eﬃciency of lysozyme was
aﬀected by the ratio of monomer to crosslinker. Relatively
eﬃcient lysozyme encapsulation was obtained at a monomer–
crosslinker ratio above 15, where a critical mesh size was
attained. The half-life of nanogels is affected by the mono-
mer–crosslinker ratio, e.g. at a ratio of 7, nanogels showed a
half-life of 90 min at pH 5.8 compared to B57 h at pH 7.4.
The research group of Narain has reported thermo- and pH-
sensitive biodegradable cationic nanogels based on carbohydrate
as eﬀective gene delivery carriers.29 Nanogels containing a cationic
thermosensitive core, which allows a facile complexation with DNA,
were crosslinked with an acid-cleavable linker, 2,2-dimethacroyloxy-
1-ethoxypropane. The acid-cleavable property of nanogels facili-
tated the degradation of nanogels at endosomal pH, which
intracellularly released the complexed DNA. These dual respon-
sive nanogels exhibited low toxicities and high gene expression,
making them potential candidates for gene expression vectors.
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Table 2 Labile crosslinkers used in degradable micro- and nanogels
Crosslinkers Structure Cleavable conditions Ref.
Acid-cleavable
Hydrazone linker pH 5.5, 100% degradation within 200 min,10 times faster than pH 7.5 126, 134, 135
Imine linker pH 5, cleavable within 3 h 65
Acetal linker
Bisacrylamide acetal with a p-methoxy substituent,
pH 5, half-life 5.5 min; slightly acidic pH,
complete hydrolysis o1 h
32, 127
Ketal linker pH 5.5, half-life 2 h 175
Vinyl ether Hydrolysis at pH o 5 143
Carboxylate ester Hydrolysis under physiological conditions 130
Boronate ester pH 5, cleavage in 120 min 88, 89, 176
Carbonate Complete degradation under physiologicalconditions after 6 days 26
Photo-cleavable
ortho-Nitrobenzyl ester UV 315–390 nm 158
Biscoumarin UV o 260 nm 74
Redox-cleavable
Disulfide DTT, TCEP, GSH 35, 36, 38, 48, 73,101, 151, 152
Enzyme-cleavable
Phosphoester Phosphatase, phospholipase 42, 76
Reversible click reactions
Retro-Diels–Alder
DMF can accelerate retro-DA reaction;
degradation by retro-DA reaction first
at body temperature.
162, 164
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3.1.2. Ester
3.1.2.1. Carboxylate ester.Matyjaszewski et al. have prepared
a biodegradable POEO300MA-co-PHEMA nanogel with hydro-
lytically labile crosslinkers by electron transfer ATRP via inverse
miniemulsion.130 They have further fabricated a hyaluronic
acid (HA) nanostructured hydrogel from the acryloyl chloride
functionalized nanogels and thiol-derivatized HA (HA-SH) via a
Michael-type addition reaction. The polyester was reported
to be degradable under physiological conditions through the
cleavage of the ester bond.131,132 The degradable hydrogels are
Table 2 (continued )
Crosslinkers Structure Cleavable conditions Ref.
Retro-Michael addition GSH, 10 times slower than disulfidecrosslinks 165, 166
Additive-induced dissociation
Boronate ester Glucose 91
Cholesteryl-induced assembly — Cyclodextrin 102, 105, 137,
170, 171
Fig. 15 AFM images of the degradation process of polyglycerol nanogels (a–h, scan size: 5  5 mm) over time in the liquid state. Picture (i) shows the
nanogel residue under ambient conditions after degradation (scan size: 2  2 mm). Reprinted with permission from ref. 128. Copyright 2014 Wiley-VCH.
Fig. 16 Synthetic approach for acid-labile PNVF nanogels. Reproduced from ref. 129. Copyright 2008 American Chemical Society.
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potential candidates for tissue engineering and cell encapsula-
tion, while the nanogels facilitate the controlled release of
small biomolecules by taking advantage of a second delivery
carrier in addition to the macroscopic matrix.
3.1.2.2. Boronate ester. Narain et al. have prepared thermo-,
pH- and glucose- responsive hydrogels and nanogels via boronic–
diol interaction between poly(N-isopropylacrylamide-st-5-meth-
acrylamino-1,2-benzoxaborole) and the glycopolymers (Fig. 9).91
The hydrogels were completely dissociated in weakly acidic
solution due to the cleavage of the boronate ester as well as in
excess glucose solution, because the competitive complexation
of glucose molecules with benzoxaborole caused the dissociation
of the glycopolymers from the gels.
Our group has developed a boronate crosslinked nanogel
system that has been introduced in Section 2.1.7. The nanogel
swelled at pH 5 after 24 h incubation and completely degraded
at pH 4. The MTX-loaded nanogel could partially release the drug
in the mildly acidic environment in endo/lysosomal compartments
after endocytosis, resulting from the partial cleavage of boronate
ester bonds. Moreover, the electrostatic repulsion and the partial
cleavage of the boronate linkages induced the swelling of
the nanogel and thus facilitated the nanogel breaking up the
endo/lysosomal membrane (Fig. 17).92
3.1.2.3. Carbonate. The research group of Smedt has
reported the preparation of cationic biodegradable microgels
by copolymerization of dextran hydroxylethyl methacrylate (dex-
HEMA) with dimethyl aminoethyl methacrylate (DMAEMA) and the
incorporation of siRNA in the hydrogel network.133 The carbonate
ester crosslinks hydrolyzed at pH 7.4, which resulted in the release
of siRNA from the microgels. They concluded that the crosslinking
density can aﬀect the degradation rate and therefore govern the
siRNA release profile.
Afterwards, Smedt et al. also engineered biodegradable
cationic dextran nanogels by inverse emulsion photopolymeriza-
tion as potential siRNA carriers.27 The degradation of dex-HEMA
nanogels, which is a prerequisite for eﬃcient gene silencing in the
absence of endosomolytic tools, showed a pH-dependent tendency
with a faster hydrolysis at physiological pH than at acidic pH.
With controllable degradation kinetics, the nanogels could be
suitable for prolonged, time-controlled gene silencing uses.
3.1.3. Imine linker. Yang et al. fabricated composite microgel
capsules by in situ surface crosslinking through benzoic–imine
linkages, which are formed between the amino groups of glycol
chitosan (GC) and benzaldehyde bifunctionalized poly(ethylene
glycol) (OHC–PEG–CHO).39 The gel capsules swell with decreasing
pH due to the lability of the imine linkage at acidic pH, causing
degradation of crosslinkers. Later on, they also synthesized protein
nanogels by crosslinking urokinase with OHC–PEG–CHO.65
The crosslinked structure efficiently maintained the stability
of the protein by preventing enzyme degradation, which can
keep it stable under physiological conditions and dissociated at
acidic pH, resulting in reversible bioactivity of the protein in
the intracellular compartments.
3.1.4. Hydrazone linker. The hydrazone linker is hydrolyti-
cally cleavable, particularly at low pH values, and the hydrolysis
rate is negatively related to the pH value.134 Degradation of
the hydrazone bond is more than 10 times faster at pH 5.5 than
at pH 7.4. The hydrazone linker has been used for the design of
acid-degradable linear polymers, crosslinked nanoparticles,
and polymer-conjugated prodrugs.126,135
Hydrazone bonds have been widely used as crosslinkers in
hydrogels.136,137 Hoare et al. reported injectable hydrazone-
crosslinked hydrogels formed by hydrazide functionalized polymer
and aldehyde functionalized carbohydrate.137 Degradation of the
hydrogel was monitored at various concentrations of hydrochloric
acid. With increasing concentration of H+, the degradation rate
Fig. 17 Intracellular pathway of MTX-loaded nanogels: (1) passive targeting and endocytosis of the nanogel, (2) acidity-induced nanogel swelling and
protonation of amino groups, (3) rupture of the organelle membrane, (4) endo/lysosomal membrane permeation, (5) ATP-triggered dissociation of the
nanogel. Reprinted with permission from ref. 92. Copyright 2014 Wiley-VCH.
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increased, confirming that the acid-catalyzed hydrolysis of the
hydrazone bond is the driving force for hydrogel degradation.
Ossipov and coworkers have constructed a hyaluronic acid
(HA) hydrogel by employing the thiol–disulfide exchange reaction
and carbazone chemistry. Both DOX and HA were linked to the
poly(vinyl alcohol) (PVA) backbone, and the release of DOX was
observed more efficiently at acidic pH than under neutral condi-
tions due to the acid-cleavability of the carbazone bond.136
However, the use of the hydrazone bond as the crosslinker of
micro- and nanogels has not been reported yet. Besides, it has
also been used as the linker between drugs and carriers, which
can reduce the side eﬀects towards normal tissues and cells and
improve the eﬃcacy in killing tumor cells due to the suﬃcient
stability of the hydrazone linker at physiological pH, whereas
eﬃcient cleavability in acidic conditions (tumor tissue and
intracellular compartments).135,138,139
3.1.5. Vinyl ether. Thompson and Akiyoshi et al. have
developed self-assembled nanogels composed of acid-labile
cholesteryl-modified pullulan (acL-CHP) via a click reaction
(Fig. 18a and b). The hydrolysis of cholesteryl vinyl ether groups
was rapid (B1 h) at acidic pH,140–142 but the degradation of
acL-CHP nanogels was much slower, probably due to the
formation of a more stable acetal intermediate (Fig. 18c), which
is hydrolyzed much slower than vinyl ethers at acidic pH. The
formation of acetal byproducts may have produced protein–
nanogel complexes so that the release rate of the BSA cargo was
slower than the hydrolysis rate of the acL-CHP nanogels under
acidic conditions.143
3.2. Redox cleavable
In addition to pH-cleavable crosslinks, the reduction-responsive
crosslinks, which make use of the redox gradients between the
oxidizing extracellular medium and the reductive intracellular
environments, are also well-known with regard to producing bio-
responsive hydro-, micro- and nanogels.144 Glutathione (GSH)
tripeptide, the most abundant reducing agent in the intracellular
environment, exists in the milli-molar range (B1–11 mM) in
cytosol and in the micro-molar range (B10 mM) in extracellular
fluids.145–148 Moreover, it has been found that the GSH level is even
higher in cancer cells than in normal cells.149,150 The disulfide links
are stable during the blood circulation but are efficiently cleaved
under the intracellular reductive conditions, which enables rapid
drug release and facilitates the site-specific delivery of anti-tumor
drugs in cancer therapeutics.125,151
Matyjaszewski et al. have constructed biodegradable nanogels
with disulfide-functionalized dimethacrylate (DMA) crosslinkers
by inverse miniemulsion atom transfer radical polymerization
(ATRP).48 The nanogels were degraded into individual polymeric
chains in GSH solution, which enables both the release of
encapsulated cargos and the removal of blank carriers.
Furthermore, Thayumanavan and coworkers designed disulfide
crosslinked polymeric nanogels based on an oligoethyleneglycol
Fig. 18 (a) Degradation of the acL-CHP nanogel at acidic pH. (b) Chemical structure of acL-CHP. (c) Hypothesis of the hydrolysis mechanism of
cholesteryl vinyl ether group under acidic conditions. Reprinted with permission ref. 143. Copyright 2013 American Chemical Society.
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(OEG)-containing random copolymer with pyridyl disulfide
(PDS) side chains, by a simple thiol–disulfide exchange reaction
without using organic solvents, metal-containing catalysts, or
additional reagents.152 The stability of the noncovalent dye
encapsulation inside the nanogels can be adjusted by varying
the crosslinking density, which has been demonstrated by in vitro
fluorescence resonance energy transfer (FRET) experiments.
The nanogels showed favorable stability by preventing the guest
molecules from leaching prior to endocytosis. The release of
encapsulated DOX is triggered by GSH treatment due to the
cleavage of the disulfide crosslinks, producing drug-induced
cytotoxicity to tumor cells.
These nanogels are surface functionalized with thiol-
modified Tat peptide or FITC via the thiol–disulfide exchange
reaction with residual PDS functionalities in the nanogels.36
By using the same method, the group of Matyjaszewski func-
tionalized the nanogels with different cysteine-modified ligands,
including folic acid, cyclic arginine–glycine–aspartic acid (cRGD)
peptide, and cell-penetrating peptide.35 RGD- and folic acid-
modified nanogels exhibit superior cellular uptake by cells over-
expressing integrin and folate receptors, whereas cell-penetrating
peptide-decorated nanogels result in rapid nonspecific uptake by
the cells. The hydrophobic chemotherapeutic drugs can be stably
encapsulated, delivered to the specific receptor-rich cells, and
released inside the cells because of the cleavage of disulfide
crosslinks under intracellular reductive conditions.
Zhong and coworkers developed reductive degradable nano-
gels depending on the in situ crosslinking of poly(ethylene
glycol)-b-poly(2-(hydroxyethyl) methacrylate-co-acryloyl carbonate)
(PEG-P(HEMA-co-AC)) block copolymers with cystamine via
a nucleophilic ring-opening reaction for intracellular protein
delivery (Fig. 19).34 The model protein cytochrome C (CC)
was encapsulated under mild conditions with high loading
and exhibited a limited immature release under physio-
logical conditions. The proteins were released without dena-
turation under intracellular reductive conditions due to the
de-crosslinking of the nanogels, showing better antitumor
activity than free CC.
Very recently, we developed charge-conversional and reduction-
sensitive polyvinyl alcohol (PVA) nanogels for eﬃcient cancer
treatment by enhanced cell uptake and intracellular triggered
doxorubicin (DOX) release. Interestingly, confocal laser scanning
microscopy (CLSM) revealed that these ultra pH-sensitive nanogels
could reverse their surface charge from negative to positive for
improved cell internalization at a tumor extracellular pH (6.5–6.8).
Furthermore, MTT assays and real time cell analysis (RTCA)
showed that these DOX-loaded nanogels had a significant cell
toxicity following 48 h of incubation.153
Du and Li et al. have described the preparation of thermo-,
pH-, and redox-responsive nanogels by copolymerization of
monomethyl oligo(ethylene glycol) acrylate (OEGA) and 2-(5,5-
dimethyl-1,3-dioxan-2-yloxy) ethyl acrylate (DMDEA), an acrylic
monomer containing ortho ester, with a crosslinker bis(2-
acryloyloxyethyl) disulfide (BADS) via miniemulsion.151 As shown
in Fig. 20, the cleavage of the disulfide crosslinks in these nanogels
produced water-soluble polymers, which probably promotes kidney
elimination. However, single polymer chains below 20 nmwere not
detected by DLS after degradation of the nanogels by DTT, probably
owing to some unbreakable linkages formed by chain transfer
to the disulfide bond in the process of radical polymerization.
The hydrophobic drugs, paclitaxel (PTX)- and DOX-loaded nano-
gels, showed good stability at physiological pH with or without
serum and bio-responsive (acidic pH and redox potential) release
behaviors. The PTX-loaded nanogels display concentration-
dependent toxicity to tumor cells.
We have recently developed a pH- and redox-responsive
prodrug nanogel, in which DOX was conjugated via an acid-
labile hydrazone linker, based on a thiol–disulfide exchange
reaction by an inverse nanoprecipitation method (Fig. 6).38 The
prodrug nanogels remained stable under physiological conditions,
and the size was big enough for the enhanced permeation and
retention (EPR) effect in tumor tissue. These nanogels were
Fig. 19 Schematic illustration of the formation of reduction-sensitive nanogels for protein loading and reduction-triggered release. Reprinted with
permission from ref. 34. Copyright 2013 American Chemical Society.





























































































1966 | Chem. Soc. Rev., 2015, 44, 1948--1973 This journal is©The Royal Society of Chemistry 2015
efficiently internalized into the tumor cells by endocytosis, ending
up in the endosome/lysosome, where the hydrazone linker
was cleaved at decreasing pH values. Rapid release of DOX
occurred as soon as the nanogels were degraded in the cytosolic
reductive environment.
3.3. Photo cleavable
Photochemical reactions are easy to spatiotemporally control,
in other words, the reactions can be controlled by when and
where light is delivered to the systems,154,155 which makes them
potential cytocompatible reactions.156 However, ultraviolet light
can cause toxicity in the range of mid UV (280–315 nm) and
far UV (200–280 nm). Therefore, the functional wavelength is
of great importance when photochemistry is applied in the
biomedical fields.
ortho-Nitrobenzyl (Fig. 21) is one of the most important and
useful photolabile groups in biomedical applications due to its
biocompatibility and the inertia of the residues both before and
after photodegradation for fragile biomacromolecules, such as
proteins, DNAs, and RNAs.157
Landfester et al. have reported an easy way to prepare dual-
responsivemicrogels with photodegradable crosslinkers containing
an o-nitrobenzylic group by inverse miniemulsion copolymeriza-
tion.158 The model protein myoglobin was eﬃciently loaded and
showed a two-step release: first a slow diﬀusion controlled release
induced by pH changes and subsequently a fast degradation
controlled on-demand release induced by photo irradiation.
Zhao and coworkers have developed thermal- and photo-
responsive core–shell nanogel particles based on the self-
assembly of a double-hydrophilic block copolymer, containing
coumarin moieties in aqueous solution.159 Photodimerization
of coumarin under UV irradiation (l4 310 nm) resulted in both
core- and shell-cross-linked nanogels that exhibited photocleavage
at l o 260 nm, which caused the nanogels to swell.
3.4. Enzyme cleavable
Enzymatically degradable micro- and nanogels have been
employed in biomedical applications, such as site-specific drug
delivery, since the enzyme concentration is cell- and tissue type-
dependent, which enables the trigger of local drug release.42,76,154
The group of Wang has synthesized enzymatically cleavable nano-
gels, based on block copolymers containing a polyphosphoester,
which undergoes hydrophobic-to-hydrophilic transition induced by
salt, by a template-free method via photo-crosslinking.76 DOX was
loaded using a ‘‘breathe-in’’ method and released with acceleration
by phosphodiesterase I enzyme, which exists in mammalian
cells and has been reported to catalyze the phosphoester linker
degradation.
Later on, they engineered polyphosphoester core-crosslinked
nanogels decorated with mannosyl ligands on the PEG shell for
targeted antibiotic delivery (Fig. 22a).42 Vancomycin, a model
hydrophilic antibiotic, was loaded into the nanogels, and released
after the degradation of the nanogels triggered by the active
bacterial enzyme, phosphatase or phospholipase. As shown in
Fig. 22b, the mannosylated nanogels preferentially delivered
the loaded antibiotic to macrophages and also entered into the
bacterial infection site in vivo, to inhibit the growth of the
model bacterium, a methicillin-resistant strain of Staphylococcus
aureus (MRSA), MW2, by an enzyme-triggered release of the
antibiotic vancomycin.
3.5. Reversible click reactions
The reversible click reactions have restricted applications in the
biomedical field because harsh degradation conditions are
required, such as high temperature,160 ultrasonics,161 organic
solvents,162 and so on. To date, no utilization of reversible click
reactions has been reported in micro- and nanogel degradation.
Herein, we only show some examples of hydrogels where these
reactions have been applied.
3.5.1. Retro-Diels–Alder reaction (retro-DA reaction). Wei
et al. have synthesized thermo-sensitive hydrogels based on
diene or dienophile functionalized polymers by a DA-reaction
under mild conditions with the advantages of initiator- or
catalyst-free, organic solvent-free, tunable gelation rate, and
thermal reversibility.162 The gelation occurs at low tempera-
tures and can be accelerated by increasing the temperature.
The hydrogels are stable in water even at high temperature,
but are dissociable in DMF because the retro-DA reaction is
accelerated by DMF.
The research group of Shoichet has designed hyaluronic acid
(HA) based hydrogels from furan-modified HA and dimaleimide-
decorated PEG by a one-step DA ‘‘click’’ reaction in aqueous
solution, which showed cytocompatibility, a similar elastic modulus
to the central nervous system tissue, minimal swelling, and com-
plete degradation.163 All these properties make them potential
candidates for soft tissue engineering.
Fig. 20 Synthetic pathway and stimuli-responsive behavior of nanogels.
Reprinted with permission from ref. 151. Copyright 2011 Wiley-VCH.
Fig. 21 Photodegradation of the ortho-nitrobenzyl ester derivative.
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Goepferich et al. have first reported that the degradation of
hydrogels by retro-DA reactions can occur at body tempera-
ture.164 Maleimide and furyl-functionalized branched PEG
macromonomers were synthesized and used to prepare hydro-
gels by DA reactions. Hydrogel degradation, which was caused
by the retro-DA reaction and the subsequent hydrolysis of
maleimides to maleamic acid derivatives, was dependent on
the concentration of the polymer and the type of the used
macromonomers.
3.5.2. Retro-Michael addition reaction. Kiick and coworkers
have investigated the degradability of the succinimide thioether
formed by the thiol–maleimide Michael addition reaction, which
is generally considered a stable bond, in the presence of excess
reductant under physiological conditions.165 They further employed
the retro-Michael addition reaction to produce hydrogels with
GSH-sensitive linkages, succinimide–thioether, the cleavage of
which was 10-fold slower than that of disulfide crosslinkers,
which induced prolonged drug release.166
3.6. Additive cleavable
Narain et al. have synthesized multi-responsive gels formed via
boronic–diol interaction as discussed in Section 2.1.7. The
crosslinked network was destroyed in glucose solution due to the
glucose molecules competitively interacting with benzoxaborole,
dissociating the glycopolymer from the complex.91
Adenosine-50-triphosphate (ATP) is a multifunctional nucleotide
with the intracellular concentration in the range of 1 to 10 mM,
which is much higher than its extracellular concentration
(o5 mM).167 This concentration gradient was used by our group
to promote the intracellular degradation of nanogels and release
of drug payload (as illustrated in Sections 2.1.7 and 3.1.2.2,
Fig. 10 and 17). In the presence of 5 mM ATP, the nanogel was
dissociated into small fragments below 10 nm after 24 h,
resulting in an enhanced release rate of MTX.
4. Supramolecular crosslinking and
dissociation
Noncovalent interactions, such as ionic interactions, hydro-
phobic interactions, hydrogen bonding, or combinations thereof,
can be used to physically crosslink macromolecules to obtain cell-
compatible micro- and nanogels. Supramolecularly crosslinked
gels aﬀord a simple network formation without the use of any
potentially toxic chemical crosslinkers or initiators. The degrada-
tion can be triggered via external stimuli by disturbing the
interactions of the noncovalent crosslinks.154
4.1. UV-induced dissociation
Yuan et al. have designed and synthesized a photoresponsive
microgel by combining a noncovalent assembly process with a
covalent crosslinking method by the host–guest interaction
between azobenzene-functionalized poly(ethylene glycol) [(PEG-
(Azo)2)] and acrylate-modified b-CD (b-CD-MAA), to form a
photoresponsive inclusion complex, which was crosslinked by
thiol-functionalized PEG (PEG-dithiol) via a Michael addition
click reaction.168 Upon UV irradiation at 365 nm, the spherical
particles with a diameter of 200–250 nm decreased to 40–60 nm
due to the photoisomerization of PEG-(Azo)2 from trans- to cis-,
inducing the dissociation of the microgel, which was still cross-
linked by PEG-dithiol. The size of the microgel could return
under visible light treatment at 450 nm. Therefore, the size of the
microgel particles can be reversibly controlled by dissociation
and association of the b-CD–azobenzene inclusion complex
induced by alternative irradiation of UV and visible light.
4.2. Cyclodextrin-induced dissociation
Akiyoshi et al. have described the complexation of protein with
hydrogel nanoparticles by the self-assembly of cholesteryl
group-bearing pullulan (CHP) to prevent protein denaturation
Fig. 22 (a) The structure of vancomycin-loaded mannosylated nanogels (MNG-V) and bacteria-responsive drug release, (b) targeted uptake and
transport of MNG-V, drug release, and bacteria inhibition. Reprinted with permission from ref. 42. Copyright 2012 Wiley-VCH.
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and aggregation.169,170 The dissociation of nanogels, which
induces the release of protein, depends on the concentration
and types of cyclodextrins used. b-CD was more eﬀective than
other CDs in dissociating the CHP nanogels171 induced by the
formation of inclusion complexes of CD with CHP.172 They
demonstrated a cell-free protein synthesis technique with
nanogel-based artificial chaperones to rapidly produce proteins
and improve the folding eﬃciency. Rhodanese was successfully
expressed in the presence of the nanogel without aggregation
and folded to the enzymatically active form upon addition of a
dissociation agent like CD.105
They have further fabricated an injectable hydrogel by salt-
induced association of a hyaluronic acid (HA)-based anionic
nanogel, which was formed by the self-assembly of cholesteryl-
group-bearing HA, for the delivery of recombinant human
growth hormone (rhGH) (Fig. 23).102 The driving force to load
protein is its hydrophobic interaction with cholesteryl groups,
which can form inclusion complexes with added CD deriva-
tives, thus dissociating the CHP nanogels to release the pro-
teins. The salt-induced injectable hydrogel with its ability to
maintain a narrow range of rhGH levels in the plasma for over
one week provides an easy formulation for sustained release of
therapeutic proteins.
To overcome various obstacles and achieve both spatial and
temporal precision disintegration, reversible crosslinked
micro- and nanogels with sophisticated structural and func-
tional properties, which are in response to one stimulus or a
combination of diﬀerent stimuli, are attracting more and more
attention. The internal biological stimuli, pH, redox potential,
and enzyme, are beneficial for self-controllable release systems
in clinical trials, whereas external signals like light and
additives can precisely release the drug in a temporal-, spatial,
and dose-controllable mode by switching on or oﬀ on demand.
By taking advantage of the merits of diﬀerent stimuli, the
cleavable micro- and nanogels now possible in theory possess
promising potential in practice.
5. Conclusions and future
perspectives
In this review, we highlighted the recent progress in covalent
and supramolecular crosslinking methodologies to prepare
micro- and nanogels. We compiled diﬀerent cleavable cross-
linking strategies incorporated in them, which are mostly used
in the field of biomedical applications. Covalently crosslinked
gel networks can maintain adequate mechanical stability and
help deliver the encapsulated payload at the targeted site by
surviving the harsh in vivo conditions when adjusted in the right
way. However, the crosslinking agents are often toxic and cause
unspecific interaction with the bioactive payloads. In contrast,
supramolecular crosslinked networks are normally formed in
aqueous solution, which avoids adverse eﬀects, but their stability
is not yet satisfying in most of the studied systems.
To date, the most common synthetic method for the pre-
paration of covalently crosslinked micro- and nanogels from
precursors without amphilicity has been emulsion or inverse
emulsion polymerization, in which the surfactants are essential
and must be thoroughly removed from the system. Some
surfactant-free techniques, for example, inverse nanoprecipita-
tion,38,45 have been developed very recently, but the bulk
production of the gel particles is still limited. Another approach
commonly used for the production of micro- and nanogels is
covalent/noncovalent crosslinking of self-assembled amphiphilic
polymers. These polymers, however, are often accessible only in
multistep synthesis. Therefore, further eﬀorts must be made for
the development of simple pathways with high productivity and
mild reaction conditions.
List of abbreviations
ATRP Atom transfer radical polymerization
NMP Nitroxide-mediated polymerization
Fig. 23 The formation of the HA nanogel and its solution properties. Reprinted with permission from ref. 102. Copyright 2012 Wiley-VCH.
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RAFT Reversible addition–fragmentation transfer










SPAAC Strain-promoted azide–alkyne cycloaddition
PEG-DIC Poly(ethylene glycol)-dicyclooctyne






































BMP2 Recombinant human bone morphogenetic
protein 2
FGF18 Recombinant human fibroblast growth factor 18
SLN Sentinel lymph node
DOCA-GC Deoxycholic acid-modified glycol chitosan




dex-HEMA Dextran hydroxylethyl methacrylate







OEGA Oligo(ethylene glycol) acrylate
DMDEA 2-(5,5-Dimethyl-1,3-dioxan-2-yloxy) ethyl acrylate
PTX Paclitaxel
BADS Bis(2-acryloyloxyethyl) disulfide





BSA Bovine serum albumin
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